Context Therapeutics Inc. announced the appointments of Christopher Beck as SVP of Operations. Context also announced the planned retirement of its current Head of CMC, Bill Rencher, Ph.D., who will move into an advisory role with the Company. Mr. Beck joins Context from Galera Therapeutics, where he served as VP of Program Management.

Prior to Galera, Mr. Beck spent nearly a decade at Shire where he served in roles of increasing responsiblity and created the company's first global project management and resource capacity planning capability. Throughout his career, Mr. Beck also held management positions at Merck and AstraZeneca, among others.